Allakos Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$270.5M
Industry:Biotech
Founded:N/A
Lead Investor(s):New Enterprise Associates

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Allakos's estimated annual revenue is currently $6.5M per year.
  • Allakos received $100.0M in venture funding in December 2017.
  • Allakos's estimated revenue per employee is $61,415
  • Allakos's total funding is $270.5M.

Employee Data

  • Allakos has 106 Employees.
  • Allakos grew their employee count by 43% last year.
  • Allakos currently has 10 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$7M4510%N/A-N/A
#2
N/A205N/AN/A-N/A
#3
$46.8M3024%N/A-N/A
#4
$22.3M144N/AN/A-N/A
#5
$44.3M286N/AN/A-N/A
#6
$101.2M65346%N/A-N/A
#7
$33.3M2153%N/A-N/A
#8
$28.7M1858%N/A-N/A
#9
$39.4M254N/AN/A-N/A
#10
$6.5M4214%N/A-N/A
Missing a competitor? Contribute!?
Submit

Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.

keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power

106

Number of Employees

$6.5M

Revenue (est)

10

Current Jobs

43%

Employee Growth %

$270.5M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Allakos News

09/03/2019 - Will Allakos Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor Allakos Inc. ALLK. The stock has moved higher by 1.6% in the past month, while it ...

09/08/2019 - SG Americas Securities LLC Acquires 1,040 Shares of Allakos Inc (NASDAQ:ALLK)

SG Americas Securities LLC increased its stake in shares of Allakos Inc (NASDAQ:ALLK) by 27.5% during the 2nd quarter, according to the ...

09/03/2019 - Analyst Consensus EPS Watch for Allakos Inc. (:ALLK)

Tracking the present quarter EPS consensus estimate for Allakos Inc. (:ALLK), we have noted the current number is -.45. This EPS estimate is ...

Allakos Funding

DateAmountRoundLead InvestorsReference
2014-10-01$10.0MUndisclosedMultipleArticle
2017-12-14$100.0MANew Enterprise AssociatesArticle

Allakos Executive Hires

DateNameTitleReference
2014-10-02Alejandro DorenbaumChief Medical OfficerArticle
2016-01-20Simon GreenwoodChief Business OfficerArticle